Credit rating
Company information
About Medican A/S
Medican A/S (CVR number: 39015684) is a company from GRIBSKOV. The company recorded a gross profit of -9237.3 kDKK in 2021. The operating profit was -23.5 mDKK, while net earnings were -39.7 mDKK. The profitability of the company measured by Return on Assets (ROA) was -80.1 %, which can be considered poor and Return on Equity (ROE) was -169.1 %, which can be considered poor. The equity ratio, a key indicator for solidity, stood at 39.3 %, a level that can be considered to be low. This means a higher proportion of debt in its capital structure, indicating a greater reliance on borrowed funds. Medican A/S's liquidity measured by quick ratio was 1.2 which is at a high level. Thus, the company is in a strong financial position, with liquid assets surpassing current liabilities. It is well-prepared to cover short-term financial obligations.
Financial information
See financialsGross profit (kDKK)
EBIT (kDKK)
Profitability
Solidity
Key figures (kDKK)
See financials2018 | 2019 | 2020 | 2021 | |
---|---|---|---|---|
Volume | ||||
Net sales | ||||
Gross profit | -12 456.63 | -9 763.44 | -10 145.38 | -9 237.28 |
EBIT | -17 712.41 | -22 271.85 | -26 237.10 | -23 510.19 |
Net earnings | -27 056.95 | -17 400.38 | -15 037.33 | -39 688.35 |
Shareholders equity total | 22 879.83 | 31 210.88 | 31 397.49 | 15 546.28 |
Balance sheet total (assets) | 25 226.37 | 42 849.85 | 67 823.55 | 39 605.51 |
Net debt | -4 895.97 | 454.19 | 29 203.65 | 19 241.03 |
Profitability | ||||
EBIT-% | ||||
ROA | -122.3 % | -65.1 % | -37.6 % | -80.1 % |
ROE | -118.3 % | -64.3 % | -48.0 % | -169.1 % |
ROI | -134.8 % | -80.5 % | -44.0 % | -86.1 % |
Economic value added (EVA) | -13 848.37 | -18 265.61 | -20 254.84 | -20 028.18 |
Solvency | ||||
Equity ratio | 90.7 % | 72.8 % | 46.3 % | 39.3 % |
Gearing | 3.2 % | 96.4 % | 136.0 % | |
Relative net indebtedness % | ||||
Liquidity | ||||
Quick ratio | 5.5 | 1.4 | 6.7 | 1.2 |
Current ratio | 6.7 | 1.4 | 7.1 | 1.3 |
Cash and cash equivalents | 4 895.97 | 533.28 | 1 077.16 | 1 895.42 |
Capital use efficiency | ||||
Trade debtors turnover (days) | ||||
Net working capital % | ||||
Credit risk | ||||
Credit rating | BB | BB | BB | BB |
Variable visualization
Companies in the same industry
Create your own estimates for any company
Valuation analysis
See instructions
... and more!
No registration needed.